This is illustrated by the evolving World Health Organization (WHO) classifications, with the last Edition of 2016 considering emerging/provisional entities (such as RCC with (angio)leiomyomatous stroma or ALK rearrangement-associated RCC), for which, in the meantime, additional convincing evidence has been gathered [13]. The gene discussed is ALK; the disease is renal cell carcinoma.